Gilead Sciences, Inc. (FRA:GIS)
93.94
-0.50 (-0.53%)
At close: Jun 20, 2025
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,510,547
Profits / Employee
€313,569
Market Cap
117.50B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Siemens Energy AG | 98,000 |
Siemens Healthineers AG | 72,000 |
Gilead Sciences News
- 6 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD - PRNewsWire
- 8 days ago - FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag - Benzinga
- 9 days ago - FDA approves first twice-yearly injection that prevents HIV infection - Fox News
- 9 days ago - U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects - Fortune
- 10 days ago - AHF: Gilead's Greed Kills Promise of Lenacapavir for HIV Prevention - Business Wire
- 10 days ago - Twice-a-year shot to prevent HIV approved in U.S. - CBC News
- 10 days ago - FDA approves 6-month HIV prevention shot - The Hill
- 10 days ago - Gilead Sciences Wins Approval For Highly Effective HIV Prevention Drug - Investor's Business Daily